PECAM1 and neoplasm: While infigratinib treatment alone was able to normalise blood vessels and suppress tumour proliferation, the combination treatment showed an even higher density of blood vessels, as evidenced by CD31 staining, and less proliferative cells, as indicated by the reduction in cells positively staining for p‐Histone H3 Ser10 (Figure 5B; Figure S5B).